Kingdon Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-893,580
Closed -$7.35M 82
2021
Q2
$7.35M Sell
893,580
-175,000
-16% -$1.44M 0.85% 36
2021
Q1
$9.56M Hold
1,068,580
0.98% 30
2020
Q4
$12.3M Hold
1,068,580
1.33% 17
2020
Q3
$11.1M Sell
1,068,580
-101,315
-9% -$1.05M 1.25% 21
2020
Q2
$15.4M Buy
1,169,895
+280,317
+32% +$3.69M 1.4% 16
2020
Q1
$7M Sell
889,578
-94,346
-10% -$743K 1.28% 27
2019
Q4
$20.4M Hold
983,924
3.07% 9
2019
Q3
$13.5M Buy
983,924
+55,000
+6% +$754K 1.59% 23
2019
Q2
$11.4M Buy
928,924
+44,906
+5% +$552K 1.12% 25
2019
Q1
$11M Buy
884,018
+300,000
+51% +$3.74M 1.48% 27
2018
Q4
$6.61M Buy
584,018
+9,535
+2% +$108K 1% 36
2018
Q3
$10.7M Sell
574,483
-514,737
-47% -$9.63M 0.75% 44
2018
Q2
$28.2M Buy
1,089,220
+203,000
+23% +$5.25M 1.96% 7
2018
Q1
$19.9M Hold
886,220
1.57% 15
2017
Q4
$22.2M Buy
886,220
+2,899
+0.3% +$72.6K 1.43% 12
2017
Q3
$21.4M Sell
883,321
-70,548
-7% -$1.71M 1.39% 15
2017
Q2
$19.3M Sell
953,869
-137,182
-13% -$2.77M 1.32% 22
2017
Q1
$29.4M Sell
1,091,051
-288,435
-21% -$7.76M 1.61% 14
2016
Q4
$26.2M Buy
1,379,486
+311,865
+29% +$5.93M 1.27% 16
2016
Q3
$20.9M Sell
1,067,621
-29,842
-3% -$583K 0.96% 22
2016
Q2
$16.4M Buy
1,097,463
+437,000
+66% +$6.54M 0.9% 26
2016
Q1
$6.08M Sell
660,463
-109,440
-14% -$1.01M 0.33% 54
2015
Q4
$14.8M Sell
769,903
-65,822
-8% -$1.27M 0.72% 30
2015
Q3
$12.4M Sell
835,725
-232,415
-22% -$3.45M 0.6% 32
2015
Q2
$23.4M Buy
1,068,140
+36,500
+4% +$799K 0.91% 25
2015
Q1
$23.2M Sell
1,031,640
-5,849
-0.6% -$132K 0.99% 15
2014
Q4
$20.9M Buy
1,037,489
+464,132
+81% +$9.37M 0.91% 27
2014
Q3
$10.5M Buy
573,357
+58,891
+11% +$1.08M 0.47% 51
2014
Q2
$6.91M Buy
514,466
+113,566
+28% +$1.53M 0.27% 89
2014
Q1
$6.59M Buy
+400,900
New +$6.59M 0.34% 69